Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06621680

Effect of Connective Tissue Massage on Premenstrual Syndrome

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
17 Years – 25 Years
Healthy volunteers
Accepted

Summary

This study will be conducted to investigate the effect of connective tissue massage on premenstrual syndrome.

Detailed description

Premenstrual syndrome is a collection of emotional, physiological and behavioral symptoms that develop around the end of the luteal phase and fade away with or after mensturation. The physiological effects of connective tissue massage (CTM) are both local and general. Local effects include release of histamine from mast cells which leads to a triple response, local swelling and arteriolar dilatation mediated by local axon reflexes. The increased blood flow to the region assists resolution of subacute or chronic inflammation and reduces pain by removing nocigenic chemicals from the tissues. The mechanical distortions produced by CTM strokes help to mobilize connective tissue and improve function. Few studies have investigated the effect of the CTM on premenstrual syndrome in adolescent females. So this study will be conducted to add new information about the effect of connective tissue massage on premenstrual syndrome, which may help adolescent females suffering from this syndrome in decreasing their symptoms, thus adding new information to the field of physical therapy.

Conditions

Interventions

TypeNameDescription
DRUGMultivitaminsAll participants will receive multivitamins (vitatron) capsule once daily, for 12 weeks.
OTHERConnective tissue massageConnective tissue massage will be applied on (Sacral, lumbar, last thoracic vertebrae-T12, and subcostal regions), 2 sessions/week for 20 minutes each session for 12 weeks. Treatment will begin 3 days before menstruation to the 4th day of menstruation for 3 successive menstrual cycles.

Timeline

Start date
2024-10-10
Primary completion
2025-04-01
Completion
2025-04-15
First posted
2024-10-01
Last updated
2024-10-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06621680. Inclusion in this directory is not an endorsement.